Αποτελέσματα αναζήτησης - "МНОГОСОСУДИСТОЕ ПОРАЖЕНИЕ КОРОНАРНОГО РУСЛА"

1

Academic Journal

Redistribution of Perfusion and Myocardial Function in Patients With Multivessel Disease and Myocardial Infarction With ST Segment Elevation After Recanalization of an Infarct-Associated Artery According to the Results of Single Photon Emission Computed Tomography, Synchronized With Electrocardiography ; Перераспределение перфузии и функции миокарда у пациентов с многососудистым поражением и острым инфарктом миокарда с элевацией сегмента ST после реканализации инфаркт-связанной артерии по результатам однофотонной эмиссионной компьютерной томографии, синхронизированной с электрокардиографией

Συγγραφείς: I. M. Kuzmina, E. N. Ostroumov, O. G. Sinyakova, N. Y. Kudryashova, E. D. Kotina, M. V. Parkhomenko, И. М. Кузьмина, Е. Н. Остроумов, О. Г. Синякова, Н. Е. Кудряшова, Е. Д. Котина, М. В. Пархоменко

Πηγή: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 11, № 4 (2022); 573-583 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 11, № 4 (2022); 573-583 ; 2541-8017 ; 2223-9022

Θεματικοί όροι: ОФЭКТ-ЭКГ, multivessel coronary disease, perfusion and myocardial function, right ventricular dilatation, SPECT-ECG, многососудистое поражение коронарного русла, перфузия и функция миокарда, дилатация правого желудочка

Περιγραφή αρχείου: application/pdf

Relation: https://www.jnmp.ru/jour/article/view/1514/1233; https://www.jnmp.ru/jour/article/view/1514/1252; Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165. PMID: 30165437 https://doi.org/10.1093/eurheartj/ehy394; Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377(25):2419–2432. PMID: 29083953 https://doi.org/10.1056/NEJMoa1710261; Adriaenssens T, Van de Werf F. Is Culprit-Lesion-Only PCI in Cardiogenic Shock Still Better at 1 Year? N Engl J Med. 2018;379(18):1775–1776. PMID: 30380397 https://doi.org/10.1056/NEJMe1810971; Weil BR, Canty JM. Coronary Blood Flow and Myocardial Ischemia. In: Rosendorff C. (ed.) Essential Cardiology. 3rd ed. New York, NY: Springer; 2013. Ch.34. p. 387–403. https://doi.org/10.1007/978-1-4614-6705-2; Johnson NP, Kirkeeide RL, Gould KL. Coronary Steal: Mechanisms of a Misnomer. J Am Heart Assoc. 2021;10(13):e021000. PMID: 34187172 https://doi.org/10.1161/JAHA.121.021000; Gould KL, Gewirtz H, Narula J. Coronary blood flow and myocardial ischemia / In: Fuster V, Harrington RA, Narula J, Eapen ZJ. (eds.) Hurst’s the heart. 14th ed. New York: McGraw Hill; 2017. p. 893–922.; Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, et al. Complete Revascularization with Multivessel PCI for Myocardial Infarction. N Engl J Med. 2019;38(15):1411–1421. https://doi.org/10.1056/NEJMoa1907775; Lee C, Chong S, Hsueh S, Chung W-J, Cheng C-I. Residual Right Coronary Artery Stenosis after Left Main Coronary Artery Intervention Increased the 30-Day Cardiovascular Death and 3-Year Right Coronary Artery Revascularization Rate. J Interv Cardiol. 2020; 2020:1–8. https://doi.org/10.1155/2020/4587414; Hamalainen H, Corovai A, Laitinen J, Laitinen TM, Hedman M, Hedman A, et al. Myocardial ischemia and previous infarction contribute to left ventricular dyssynchrony in patients with coronary artery disease. J Nucl Cardiol. 2021;28(6):3010–3020. PMID: 32869165 https://doi.org/10.1007/s12350-020-02316-9; Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction. J Am Coll Cardiol. 2018;72(18):2231–2264. PMID: 30153967 https://doi.org/10.1016/j.jacc.2018.08.1038; Kotina E, Ostroumov E, Ploskikh V. Left and Right Ventricular Phase Analysis of Gated SPECT Myocardial Perfusion. Eur J Nucl Med Mol Imaging. 2012;39(Suppl 2):S213. https://doi.org/10.1007/s00259-0122221-x; Лишманов Ю.Б., Чернов В.И. (ред.) Национальное руководство по радионуклидной диагностике. В 2-х т. Т. 2. Томск: STT; 2010.; https://www.jnmp.ru/jour/article/view/1514

Διαθεσιμότητα: https://www.jnmp.ru/jour/article/view/1514
https://doi.org/10.23934/2223-9022-2022-11-4-573-583

View record from BASE

2

Academic Journal

PREVALENCE OF PRE-FRAILTY AND FRAILTY IN PATIENTS WITH MULTIVESSEL CORONARY ARTERY DISEASE ; РАСПРОСТРАНЕННОСТЬ ПРЕАСТЕНИИ И СИНДРОМА СТАРЧЕСКОЙ АСТЕНИИ У ПАЦИЕНТОВ С МНОГОСОСУДИСТЫМ ПОРАЖЕНИЕМ КОРОНАРНОГО РУСЛА

Συγγραφείς: Kristina E. Krivoshapova, Denis A. Tsygankov, Daria P. Tsygankova, Olga L. Barbarash, Кристина Евгеньевна Кривошапова, Денис Анатольевич Цыганков, Дарья Павловна Цыганкова, Ольга Леонидовна Барбараш

Συνεισφορές: Работа выполнена при поддержке гранта РНФ № 22-15-00305 «Патофизиологические особенности формирования остеосаркопенического ожирения при мультифокальном атеросклерозе как маркера биологического старения».

Πηγή: Complex Issues of Cardiovascular Diseases; Том 12, № 4S (2023): приложение; 25-33 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 12, № 4S (2023): приложение; 25-33 ; 2587-9537 ; 2306-1278

Θεματικοί όροι: Распространенность, Frailty, Multivessel coronary artery disease, Coronary artery disease, Prevalence, Синдром старческой астении, «Хрупкость», Многососудистое поражение коронарного русла, Ишемическая болезнь сердца

Περιγραφή αρχείου: application/pdf

Relation: https://www.nii-kpssz.com/jour/article/view/1385/861; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1385/1435; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1385/1436; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1385/1437; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1385/1438; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1385/1440; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1385/1441; Masnoon N., Shakib S., Kalisch-Ellett L., Caughey G.E. What is polypharmacy? A systematic review of definitions. BMC Geriatrics. 2017; 17 (1): 230. doi:10.1186/s12877-017-0621-2; Payne R.A. The epidemiology of polypharmacy. Clinical medicine (London, England). 2016; 16 (5): 465-469. doi:10.7861/clinmedicine.16-5-465; Tinetti M.E., Fried T. The end of the disease era. Am J Med. 2004; 116 (3): 179-185. doi:10.1016/j.amjmed.2003.09.031; Cesari M., Calvani R., Marzetti E. Frailty in Older Persons. Clin Geriatr Med. 2017; 33 (3): 293-303. doi:10.1016/j.cger.2017.02.002; Morley J.E., Vellas B., van Kan G.A., Anker S.D., Bauer J.M., Bernabei R., Cesari M., Chumlea W.C., Doehner W., Evans J., Fried L.P., Guralnik J.M., Katz P.R., Malmstrom T.K., McCarter R.J., Gutierrez Robledo L.M., Rockwood K., von Haehling S., Vandewoude M.F., Walston J. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013; 14 (6): 392-397. doi:10.1016/j.jamda.2013.03.022; Collard R.M., Boter H., Schoevers R.A., Oude Voshaar R.C. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012; 60: 1487-1492. doi:10.1111/j.1532-5415.2012.04054.x; Searle S.D., Rockwood K. What proportion of older adults in hospital are frail? Lancet. 2018; 391 (10132): 1751-1752. doi:10.1016/S0140-6736(18)30907-3; Atkins J.L., Delgado J., Pilling L.C., Bowman K., Masoli Jane A.H., Kuchel G.A., Ferrucci .L, Melzer D. Impact of Low Cardiovascular Risk Profiles on Geriatric Outcomes: Evidence From 421,000 Participants in Two Cohorts. J Gerontol A Biol Sci Med Sci. 2019; 74 (3): 350-357. doi:10.1093/gerona/gly083; Veronese N., Sigeirsdottir K., Eiriksdottir G., Marques E.A., Chalhoub D., Phillips C.L., Launer L.J., Maggi S., Gudnason V., Harris T.B. Frailty and Risk of Cardiovascular Diseases in Older Persons: The Age, Gene/Environment Susceptibility-Reykjavik Study. Rejuvenation Res. 2017; 20 (6): 517-524. doi:10.1089/rej.2016.1905; Кривошапова К.Е., Вегнер Е.А., Терентьева Н.А., Масенко В.Л., Григорьева И.И., Коков А.Н., Баздырев Е.Д., Раскина Т.А., Барбараш О.Л. . Синдром старческой астении у пациентов с ишемической болезнью сердца. Медицинский алфавит. 2020; 1 (19): 6-10. doi:10.33667/2078-5631-2020-19-6-10; Кривошапова К.Е., Барбараш О.Л., Вегнер Е.А., Зинец М.Г., Иванов С.В., Барбараш Л.С. Пациент с ишемической болезнью сердца и синдромом старческой астении: характеристика мультиморбидности и прогноз госпитального периода при проведении коронарного шунтирования. Грудная и сердечно-сосудистая хирургия. 2022; 64 (2): 161-168. doi:10.24022/0236-2791-2022-64-2-161-168; Ткачева О.Н., Котовская Ю.В., Рунихина Н.К., Фролова Е.В., Наумов А.В., Воробьева Н.М., Остапенко В.С., Мхитарян Э.А., Шарашкина Н.В., Тюхменев Е.А., Переверзев А.П., Дудинская Е.Н. Клинические рекомендации «Старческая астения». Российский журнал гериатрической медицины. 2020; (1): 11-46. doi:10.37586/2686-8636-1-2020-11-46; Raîche M., Hébert R., Dubois M.F. PRISMA-7: a case-finding tool to identify older adults with moderate to severe disabilities. Arch Gerontol Geriatr. 2008; 47 (1): 9-18. doi:10.1016/j.archger.2007.06.004; Rockwood K., Song X., MacKnight C., Bergman H., Hogan D.B., McDowell I., Mitnitski A. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005; 173 (5): 489-95. doi:10.1503/cmaj.050051; Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., Seeman T., Tracy R., Kop W.J., Burke G., McBurnie M.A.; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56 (3): M146-56. doi:10.1093/gerona/56.3.m146; Luo J., Carter G.C., Agarwal J.P., Kwok A.C. The 5-Factor Modified Frailty Index as a Predictor of 30-day Complications in Pressure Ulcer Repair. J Surg Res. 2021; 265: 21-26. doi:10.1016/j.jss.2021.03.011; Santos-Eggimann B., Cuénoud P., Spagnoli J., Junod J. Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci. 2009; 64 (6): 675-681. doi:10.1093/gerona/glp012; Gurina N.A., Frolova E.V., Degryse J.M. A roadmap of aging in Russia: the prevalence of frailty in community-dwelling older adults in the St. Petersburg district--the "Crystal" study. Journal of the American Geriatrics Society. 2011; 59 (6): 980-988. doi:10.1111/j.1532-5415.2011.03448.x; Ткачёва О.Н., Воробьёва Н.М., Котовская Ю.В., Остроумова О.Д., Черняева М.С., Силютина М.В., Чернов А.В., Тестова С.Г., Овчарова Л.Н., Селезнева Е.В. Распространённость гериатрических синдромов у лиц в возрасте старше 65 лет: первые результаты российского эпидемиологического исследования ЭВКАЛИПТ. Российский кардиологический журнал. 2020; 25 (10): 3985. doi:10.15829/1560-4071-2020-3985; Hoffmann S., Wiben A., Kruse M., Jacobsen K.K., Lembeck M.A., Holm E.A. Predictive validity of PRISMA-7 as a screening instrument for frailty in a hospital setting. BMJ Open. 2020; 10 (10): e038768. doi:10.1136/bmjopen-2020-038768; Hoogendijk E.O., van der Horst H.E., Deeg D.J., Frijters D.H., Prins B.A., Jansen A.P., et al. The identification of frail older adults in primary care: comparing the accuracy of five simple instruments. Age Ageing. 2013; 42 (2): 262-5. doi:10.1093/ageing/afs163; Eredics K., Meyer C., Gschliesser T., Lodeta B., Heissler O., Kunit T., et al. Can a Simple Geriatric Assessment Predict the Outcome of TURP? Urol Int. 2020; 104 (5-6): 367-372. doi:10.1159/000506717; Lewis E.T., Dent E., Alkhouri H., Kellett J., Williamson M., Asha S., et al. Which frailty scale for patients admitted via Emergency Department? A cohort study. Arch Gerontol Geriatr. 2019; 80: 104-114. doi:10.1016/j.archger.2018.11.002; Остапенко В.С., Рунихина Н.К., Шарашкина Н.В. Распространенность синдрома старческой астении и его взаимосвязь с хроническими неинфекционными заболеваниями у пациентов амбулаторно-поликлинических учреждений г. Москвы. Российский журнал гериатрической медицины. 2020; (2): 131-137. doi:10.37586/2686-8636-2-2020-131-137; Damluji A.A., Huang J., Bandeen-Roche K., Forman D.E., Gerstenblith G., Moscucci M., Resar J.R., Varadhan R., Walston J.D., Segal J.B. Frailty Among Older Adults With Acute Myocardial Infarction and Outcomes From Percutaneous Coronary Interventions. J Am Heart Assoc. 2019; 8 (17): e013686. doi:10.1161/JAHA.119.013686; Bandeen-Roche K., Seplaki C.L., Huang J., Buta B., Kalyani R.R., Varadhan R., Xue Q.L., Walston J.D., Kasper J.D. Frailty in Older Adults: A Nationally Representative Profile in the United States. J Gerontol A Biol Sci Med Sci. 2015; 70 (11): 1427-34. doi:10.1093/gerona/glv133; Gharacholou S.M., Roger V.L., Lennon R.J., Rihal C.S., Sloan J.A., Spertus J.A., Singh M. Comparison of frail patients versus nonfrail patients ≥65 years of age undergoing percutaneous coronary intervention. Am J Cardiol. 2012; 109 (11): 1569-75. doi:10.1016/j.amjcard.2012.01.384; Вегнер Е.А., Кривошапова К.Е., Барбараш О.Л. Сложности диагностики синдрома старческой астении среди пожилого населения различных стран. Комплексные проблемы сердечно-сосудистых заболеваний. 2020; 9 (4): 95-104. doi:10.17802/2306-1278-2020-9-4-95-104

Διαθεσιμότητα: https://www.nii-kpssz.com/jour/article/view/1385
https://doi.org/10.17802/2306-1278-2023-12-4S-25-33

View record from BASE

3

Academic Journal

Multivessel coronary bed lesion in patients with stable coronary artery disease: Current state of the problem and gap in evidence ; Многососудистое поражение коронарного русла у больных со стабильной ишемической болезнью сердца: актуальное состояние проблемы и пробелы в доказательности

Συγγραφείς: A. A. Obedinskiy, N. R. Obedinskaya, N. A. Nikitin, D. A. Sirota, O. V. Krestyaninov, А. А. Обединский, Н. Р. Обединская, Н. А. Никитин, Д. А. Сирота, О. В. Крестьянинов

Πηγή: Siberian Journal of Clinical and Experimental Medicine; Том 37, № 2 (2022); 28-34 ; Сибирский журнал клинической и экспериментальной медицины; Том 37, № 2 (2022); 28-34 ; 2713-265X ; 2713-2927

Θεματικοί όροι: оптимальная медикаментозная терапия, multivessel coronary artery disease, stress CMR, myocardial revascularization, optimal medical therapy, многососудистое поражение коронарного русла, стресс-МРТ, реваскуляризация миокарда

Περιγραφή αρχείου: application/pdf

Relation: https://www.sibjcem.ru/jour/article/view/1416/706; West R.M., Cattle B.A., Bouyssie M., Squire I., de Belder M., Fox K.A. еt al. Impact of hospital proportion and volume on primary percutaneous coronary intervention performance in England and Wales. Eur. Heart J. 2011;32(6):706–711. DOI:10.1093/eurheartj/ehq476.; Emond M., Mock M.B., Davis K.B., Fisher L.D., Holmes D.R., Chaitman B.R. еt al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90(6):2645–2657. DOI:10.1161/01.cir.90.6.2645.; Lopes N.H., Paulitsch F.S., Gois A.F., Pereira A.C., Stolf N.A., Dallan L.O. еt al. Impact of number of vessels disease on outcome of patients with stable coronary artery disease: 5-year follow-up of the Medical, Angioplasty, and bypass Surgery study (MASS). Eur. J. Cardiothorac. Surg. 2008;33(3):349–354. DOI:10.1016/j.ejcts.2007.11.025.; Sukhija R., Yalamanchili K., Aronow W.S. Prevalence of left main coronary artery disease, of three- or four-vessel coronary artery disease, and of obstructive coronary artery disease in patients with and without peripheral arterial disease undergoing coronary angiography for suspected coronary artery disease. Am. J. Cardiol. 2003;92(3):304–305. DOI:10.1016/s0002-9149(03)00632-5.; Safley D.M., House J.A., Marso S.P., Grantham J.A., Rutherford B.D. Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: Variability by target vessel. JACC Cardiovasc. Interv. 2008;1(3):295–302. DOI:10.1016/j.jcin.2008.05.004.; Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U. еt al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2019;40(2):87–165. DOI:10.1093/eurheartj/ehy394.; De Bruyne B., Baudhuin T., Melin J.A., Pijls N.H.J., Sys S.U., Bol A. еt al. Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation. 1994;89(3):1013–1022. DOI:10.1161/01.cir.89.3.1013.; Pijls N.H., Fearon W.F., Tonino P.A., Siebert U., Ikeno F., Bornschein B. et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J. Am. Coll. Cardiol. 2010;56(3):177–184. DOI:10.1016/j.jacc.2010.04.012.; Tonino P.A., Fearon W.F., De Bruyne B., Oldroyd K.G., Leesar M.A., Ver Lee P.N. еt al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J. Am. Coll. Cardiol. 2010;55(25):2816–2821. DOI:10.1016/j.jacc.2009.11.096.; Greenwood J.P., Maredia N., Younger J.F., Brown J.M., Nixon J., Everett C.C. еt al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): А prospective trial. Lancet. 2012;379(9814):453–460. DOI:10.1016/S0140-6736(11)61335-4.; Chung S.Y., Lee K.Y., Chun E.J., Lee W.W., Park E.K., Chang H.J. еt al. Comparison of stress perfusion MRI and SPECT for detection of myocardial ischemia in patients with angiographically proven three-vessel coronary artery disease. AJR. Am. J. Roentgenol. 2010;195(2):356–362. DOI:10.2214/AJR.08.1839.; Nagel E., Greenwood J.P., McCann G.P., Bettencourt N., Shah A.M., Hussain S.T. еt al. Magnetic resonance perfusion or fractional flow reserve in coronary disease. N. Engl. J. Med. 2019;380(25):2418–2428. DOI:10.1056/NEJMoa1716734.; Ortiz-Pérez J.T., Rodríguez J., Meyers S.N., Lee D.C., Davidson C., Wu E. Correspondence between the 17-segment model and coronary arterial anatomy using contrast-enhanced cardiac magnetic resonance imaging. JACC. Cardiovasc. Imaging. 2008;1(3):282–293. DOI:10.1016/j.jcmg.2008.01.014.; Nakamori S., Sakuma H., Dohi K., Ishida M., Tanigawa T., Yamada A. еt al. Combined аssessment of stress myocardial perfusion cardiovascular magnetic resonance and flow measurement in the coronary sinus improves prediction of functionally significant coronary stenosis determined by fractional flow reserve in multivessel disease. J. Amer. Heart Assoc. 2018;7(3):e007736. DOI:10.1161/JAHA.117.007736.; Sammut E.C., Villa A.D., Di Giovine G., Dancy L., Bosio F., Gibbs T. еt al. Prognostic value of quantitative stress perfusion cardiac magnetic resonance. JACC Cardiovasc. Imaging. 2018;11(5):686–694. DOI:10.1016/j.jcmg.2017.07.022.; Hachamovitch R., Hayes S.W., Friedman J.D., Cohen I., Berman D.S. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107(23):2900–2907. DOI:10.1161/01.CIR.0000072790.23090.41.; Shaw L.J., Berman D.S., Maron D.J., Mancini G.B. Hayes S.W., Hartigan P.M. еt al. COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117(10):1283–1291. DOI:10.1161/CIRCULATIONAHA.107.743963.; Mohr F.W., Morice M.C., Kappetein A.P., Feldman T.E., Ståhle E., Colombo A. еt al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629–638. DOI:10.1016/S0140-6736(13)60141-5.; Ahn J.M., Park D.W., Lee C.W., Chang M., Cavalcante R., Sotomi Y. еt al. Comparison of stenting versus bypass surgery according to the completeness of revascularization in severe coronary artery disease: Patient- level pooled analysis of the SYNTAX, PRECOMBAT, and BEST trials. JACC Cardiovasc. Interv. 2017;10(14):1415–1424. DOI:10.1016/j.jcin.2017.04.037.; Xaplanteris P., Fournier S., Pijls N.H., Fearon W.F., Barbato E., Tonino P.A. еt al. Five-year outcomes with PCI guided by fractional flow reserve. N. Engl. J. Med. 2018;379(3):250–259. DOI:10.1056/NEJMoa1803538.; Zimmermann F.M., Ferrara A., Johnson N.P., van Nunen L.X., Escaned J., Albertsson P. еt al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow- up of the DEFER trial. Eur. Heart J. 2015;36(45):3182–3188. DOI:10.1093/eurheartj/ehv452.; Ghaffari S., Erfanparast S., Separham A., Sokhanvar S., Yavarikia M., Pourafkari L. The Relationship between coronary artery movement type and stenosis severity with acute myocardial infarction. J. Cardiovasc. Thorac. Res. 2013;5(2):41–44. DOI:10.5681/jcvtr.2013.009.; Giroud D., Li J.M., Urban P., Meier B., Rutishauer W. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am. J. Cardiol. 1992;69(8):729–732. DOI:10.1016/0002-9149(92)90495-k.; Little W.C., Constantinescu M., Applegate R.J., Kutcher M.A., Burrows M.T., Kahl F.R. еt al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78(5–1):1157–1166. DOI:10.1161/01.cir.78.5.1157.; Maddox T.M., Stanislawski M.A., Grunwald G.K., Bradley S.M., Ho P.M., Tsai T.T. еt al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014;312(17):1754–1763. DOI:10.1001/jama.2014.14681.; Virmani R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the vulnerable plaque. J. Am. Coll. Cardiol. 2006;47(8):C13–18. DOI:10.1016/j.jacc.2005.10.065.; Adabag A.S., Luepker R.V., Roger V.L., Gersh B.J. Sudden cardiac death: epidemiology and risk factors. Nat. Rev. Cardiol. 2010;7(4):216–225. DOI:10.1038/nrcardio.2010.3.; Almeida S.O., Budoff M. Effect of statins on atherosclerotic plaque. Trends Cardiovasc. Med. 2019;29(8):451–455. DOI:10.1016/j.tcm.2019.01.001.; Maron D.J., Hochman J.S., Reynolds H.R., Bangalore S., O’Brien S.M., Boden W.E. еt al. Initial invasive or conservative strategy for stable coronary disease. N. Engl. J. Med. 2020;382(15):1395–1407. DOI:10.1056/NEJMoa1915922.; Hussain S.T., Chiribiri A., Morton G., Bettencourt N., Schuster A., Paul M. еt al. Perfusion cardiovascular magnetic resonance and fractional flow reserve in patients with angiographic multi-vessel coronary artery disease. J. Cardiovasc. Magn. Reson. 2016;18(1):44. DOI:10.1186/s12968-016-0263-0.; Christian T.F., Miller T.D., Bailey K.R., Gibbons R.J. Noninvasive identification of severe coronary artery disease using exercise tomographic thallium-201 imaging. Am. J. Cardiol. 1992;70(1):14–20. DOI:10.1016/0002-9149(92)91382-e.; https://www.sibjcem.ru/jour/article/view/1416

Διαθεσιμότητα: https://www.sibjcem.ru/jour/article/view/1416
https://doi.org/10.29001/2073-8552-2022-37-2-28-34

View record from BASE

4

Academic Journal

Myocardial revascularization in patients with multivessel coronary lesions

Συγγραφείς: Л. С. Калугина, И. А. Урванцева

Πηγή: Патология кровообращения и кардиохирургия, Vol 20, Iss 3, Pp 14-19 (2016)

Θεματικοί όροι: ишемическая болезнь сердца, реваскуляризация миокарда, эндоваскулярная хирургия, многососудистое поражение коронарного русла, Surgery, RD1-811

Περιγραφή αρχείου: electronic resource

Relation: http://journalmeshalkin.ru/index.php/heartjournal/article/view/326; https://doaj.org/toc/1681-3472; https://doaj.org/toc/2500-3119

Σύνδεσμος πρόσβασης: https://doaj.org/article/b0ff29cb9d3d4e2e985c01d6447434d1

View record in DOAJ Full Text Finder

5

Academic Journal

Results of endovascular treatment of multivessel coronary artery disease in patients with the different stent types

Συγγραφείς: Ye R Khairutdinov, Z Kh Shugushev, D A Maximkin, A G Faibushevich, V Yu Baranovich, Yu V Tarichko

Πηγή: RUDN Journal of Medicine, Vol 0, Iss 1, Pp 65-71 (2012)

Θεματικοί όροι: многососудистое поражение коронарного русла, голометаллический стент, стент с лекарственным покрытием, Medicine

Περιγραφή αρχείου: electronic resource

Relation: http://journals.rudn.ru/medicine/article/view/3305; https://doaj.org/toc/2313-0245; https://doaj.org/toc/2313-0261

Σύνδεσμος πρόσβασης: https://doaj.org/article/7f03855c0bf445c5a4783168dbf1c51f

View record in DOAJ Full Text Finder

6

Academic Journal

Current state and challenges of surgical treatment of patients with acute coronary syndrome without ST segment elevation ; Современное состояние и проблемы хирургического лечения пациентов с острым коронарным синдромом без элевации сегмента ST (обзор)

Συγγραφείς: I. M. Skurikhin, Y. Y. Vechersky, E. V. Vyshlov, V. V. Zatolokin, Илья Максимович Скурихин, Юрий Юрьевич Вечерский, Евгений Викторович Вышлов, Василий Викторович Затолокин

Πηγή: Siberian Journal of Clinical and Experimental Medicine; Том 29, № 3 (2014); 12-18 ; Сибирский журнал клинической и экспериментальной медицины; Том 29, № 3 (2014); 12-18 ; 2713-265X ; 2713-2927 ; 10.29001/2073-8552-2014-29-3

Θεματικοί όροι: outcomes, факторы риска, медикаментозное ведение, стратегия ведения, многососудистое поражение коронарного русла, инвазивное лечение, исходы, acute coronary syndrome, risk factors, medicamentous management, medical management strategy, multivessel coronary disease, invasive treatment

Περιγραφή αρχείου: application/pdf

Relation: https://www.sibjcem.ru/jour/article/view/93/94; Болезни сердца и сосудов. Руководство Европейского общества кардиологов / под ред. А.Д. Кэмма, Т.Ф. Люшера, П.В. Серриуса; пер. с англ. под ред. Е.В. Шляхто. - М.: ГЭОТАР-Медиа, 2011. - 1480 с.; Вечерский Ю.Ю., Шипулин В.М. Современные направления хирургической реваскуляризации миокарда // Сибирский медицинский журнал (Томск). - 2010. - Т. 25, № 2, вып. 1. - С. 95.; Руководство по кардиологии / под ред. К. Коваленко. - Киев: Морион, 2008. - 1404 с.; ACC/AHA guidelines for percutaneous coronary intervention (Revision of the 1993 PTCa guidelines) - executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) // Circulation. - 2001. - Vol. 103. -P. 3019-3041.; Antman E.M., Cohen M., Bernink P.J., McCabe C.H. et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making // JAMA. - 2000. - Vol. 284. - P. 835-842.; Bassand J.P., Hamm C.W., Ardissino D. et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes // Eur. Heart J. - 2007. - Vol. 28. - P. 1598-1660.; Berger J.S., Frye C.B., Harshaw Q. et al. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis // J. Am. Coll. Cardiol. - 2008. - Vol. 52. - P. 1693-1701.; Careaga-Reyna G., Martinez-Carballo G., Villanueva-Rustrian F. et al. Coronary artery bypass graft surgery in patients with acute coronary syndrome. Analysis of results // Circulation. - 2006. -Vol. 74, No. 5. - P. 315-320.; Chew D.P., Mahaffey K.W., White H.D. et al. Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict // Am. Heart J. - 2008. - Vol. 155, No. 5. -P. 841-847.; Collet J.P., Montalescot G., Blanchet B. et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes // Circulation. - 2004. - Vol. 110. -P. 2361-2367.; Christiansen S., Autschbach R. Results and treatment strategy for patients undergoing emergent coronary artery bypass grafting // Ann. Thorac. Cardiovasc. Surg. - 2010. - Vol. 16, No. 3. - P. 168-173.; Chaudhary A., Pande S., Agarwal S.K. et al. OPCAB in acute coronary syndrome: predictors of intra-aortic balloon pump use // Indian Heart J. - 2009. - Vol. 61, No. 3. - P. 249-253.; Chen Y., Almeida A.A., Goldstein J. et al. Urgent and emergency coronary artery bypass grafting for acute coronary syndromes // ANZ J. Surg. - 2006. - Vol. 76, No. 9. - P. 769-773.; Deyell M.W., Ghali W.A., Ross D.B. et al. Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Timing of nonemergent coronary artery bypass grafting and mortality after non-ST elevation acute coronary syndrome // Am. Heart J. - 2010. - Vol. 159, No. 3. -P. 490-496.; Fitchett D., Eikelboom J., Fremes S. et al. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society // Can. J. Cardiol. - 2009. - Vol. 25. - P. 683-689.; Fox K.A., Mehta S.R., Peters R. et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial // Circulation. - 2004. - Vol. 110. - P. 1202-1208.; Fox K.A., Dabbous O.H., Goldberg R.J. et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) // BMJ. - 2006. -P. 1091-1094.; Fukui T., Shimokawa T., Manabe S., Takanashi S. Early and midterm outcome of off-pump coronary artery bypass grafting in patients with acute myocardial infarction // Kyobu Geka. - 2009. - Vol. 62, No. 1. - P. 36-40.; Giugliano R.P., White J.A., Bode C. et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes // N. Engl. J. Med. - 2009. - Vol. 360. - P. 2176-2190.; Grines C.L., Bonow R.O., Casey D.E. Jr. et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians // Circulation. - 2007. - Vol. 115. - P. 813-818.; Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European. Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) // Eur. Heart J. - 2010. - Vol. 31. -P. 2501-2555.; Held C., Asenblad N., Bassand J.P. et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery results from the PLATO (Platelet Inhibition and Patient Outcomes) Trial // J. Am. Coll. Cardiol. - 2011. - Vol. 57. - P. 672-684.; Ho P.M., Peterson E.D., Wang L. et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome // JAMA. - 2008. -Vol. 299. - P. 532-539.; Jones H.U., Muhlestein J.B., Jones K.W. et al. Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-heart surgery in patients who present with an acute coronary syndrome clinical investigation and reports // Circulation. - 2002. - Vol. 106. - P. I-19-I-22.; Kapetanakis E.I., Medlam D.A., Boyce S.W. et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist’s panacea or the surgeon’s headache? // Eur. Heart J. - 2005. - Vol. 26. - P. 576-583.; Kaya K., Cavolli R., Telli A. et al. Off-pump versus on-pump coronary artery bypass grafting in acute coronary syndrome: a clinical analysis [Электронный ресурс] // J. Cardiothorac. Surg. - 2010. - URL: http://www.cardiothoracicsurgery.org/content/5/1/31 (дата обращения: 11.11.2014).; Keller T., Zeller T., Peetz D. et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction // N. Engl. J. Med. - 2009. - Vol. 361. - P. 868-877.; Mehta R.H., Roe M.T., Mulgund J. et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery // J. Am. Coll. Cardiol. - 2006. - Vol. 48. - P. 281-286.; Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomized multicentre study. Fragmin and fast revascularisation during instability in coronary artery disease investigators // Lancet. -1999. - Р. 708-715.; Monteiro P. Portuguese Registry on Acute Coronary Syndromes. Impact of early coronary artery bypass graft in an unselected acute coronary syndrome patient population // Circulation. -2006. - Vol. 114, suppl. 1. - P. 467-472.; Paparella D., Scrascia G., Paramythiotis A. et al. Preoperative cardiac troponin I to assess midterm risks of coronary bypass grafting operations in patients with recent myocardial infarction // Ann. Thorac. Surg. - 2010. - Vol. 89, No. 3. - P. 696-702.; Parikh S.V., de Lemos J.A., Jessen M.E. et al. Crusade and action Registry-GWTG Participants. Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines) // JACC Cardiovasc. Interv. - 2010. - Vol. 3. - P. 419-427.; Sezai A., Hata M., Wakui S. et al. Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome // Circulat. J. - 2007. - Vol. 71, No. 9. - P. 1401-1407.; Song S.W., Youn Y.N., Yi G. et al. Effects of continuous administration of clopidogrel before off-pump coronary artery bypass grafting in patients with acute coronary syndrome // Circulat. J. - 2008. - Vol. 72, No. 4. - P. 626-632.; Takai H., Kobayashi J., Tagusari O. et al. Off-pump coronary artery bypass grafting for acute myocardial infarction // Circulat. J. -2006. - Vol. 70, No. 10. - P. 1303-1306.; Thielmann M., Massoudy P., Neuhäuser M. et al. Prognostic value of preoperative cardiac troponin I in patients undergoing emergency coronary artery bypass surgery with non-ST-elevation or ST-elevation acute coronary syndromes // Circulation. - 2006. - Vol. 114, No. 1, suppl. - P. 448-453.; Weiss E.S., Chang D.D., Joyce D.L. et al. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data // J. Thorac. Cardiovasc. Surg. - 2008. - Vol. 135. - P. 503-511.; Yan A.T., Yan R.T., Tan M. et al. Inhospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score // Am. J. Cardiol. - 2005. -Vol. 96. - P. 913-916.; https://www.sibjcem.ru/jour/article/view/93

Διαθεσιμότητα: https://www.sibjcem.ru/jour/article/view/93
https://doi.org/10.29001/2073-8552-2014-29-3-12-18

View record from BASE

7

Academic Journal

РЕВАСКУЛЯРИЗАЦИЯ МИОКАРДА ПРИ МНОГОСОСУДИСТОМ АТЕРОСКЛЕРОТИЧЕСКОМ ПОРАЖЕНИИ КОРОНАРНОГО РУСЛА

Συγγραφείς: КАЛУГИНА ЛИДИЯ СЕРГЕЕВНА, УРВАНЦЕВА И.А.

Θεματικοί όροι: ИШЕМИЧЕСКАЯ БОЛЕЗНЬ СЕРДЦА,РЕВАСКУЛЯРИЗАЦИЯ МИОКАРДА,ЭНДОВАСКУЛЯРНАЯ ХИРУРГИЯ,МНОГОСОСУДИСТОЕ ПОРАЖЕНИЕ КОРОНАРНОГО РУСЛА,CORONARY HEART DISEASE,MYOCARDIAL REVASCULARIZATION,ENDOVASCULAR SURGERY,MULTIVESSEL CORONARY DISEASE

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/revaskulyarizatsiya-miokarda-pri-mnogososudistom-ateroskleroticheskom-porazhenii-koronarnogo-rusla
http://cyberleninka.ru/article_covers/16996319.png

View record from BASE

8

Academic Journal

FACTORS OF MORTALITY IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH MULTIVESSEL CORONARY DISEASE AFTER ENDOVASCULAR REVASCULARIZATION ; ФАКТОРЫ ЛЕТАЛЬНОСТИ У БОЛЬНЫХ С ИНФАРКТОМ МИОКАРДА С ЭЛЕВАЦИЕЙ СЕГМЕНТА ST ПРИ МНОГОСОСУДИСТОМ ПОРАЖЕНИИ КОРОНАРНОГО РУСЛА ПОСЛЕ ЭНДОВАСКУЛЯРНОЙ РЕВАСКУЛЯРИЗАЦИИ

Συγγραφείς: R. S. Tarasov, V. I. Ganukov, Р. С. Тарасов, В. И. Ганюков

Πηγή: Complex Issues of Cardiovascular Diseases; № 1 (2015); 32-38 ; Комплексные проблемы сердечно-сосудистых заболеваний; № 1 (2015); 32-38 ; 2587-9537 ; 2306-1278 ; 10.17802/2306-1278-2015-1

Θεματικοί όροι: факторы летального исхода, multivessel coronary disease, primary PCI, factors of fatal outcome, многососудистое поражение коронарного русла, первичное чрескожное коронарное вмешательство

Περιγραφή αρχείου: application/pdf

Relation: https://www.nii-kpssz.com/jour/article/view/113/115; Чазов Е . И . Инфаркт миокарда – прошлое, настоящее и некоторые проблемы будущего. Сердце. 2002; 1:6–8. Chazov E. I. Myocardial infarction – past, present, and some of the problems of the future. Serdze. 2002; 1:6–8. [In Russ].; Ощепкова Е . В ., Ефремова Ю. Е ., Карпов Ю. А . Заболеваемость и смертность от инфаркта миокарда в Российской Федерации в 2000–2011 гг. Терапевтический архив. 2013; 4:4–10. Oshepkova E. V., Efremova Yu. E., Karpov Yu. A. Myocardial infarction morbidity and mortality in the Russian Federation in 2000–2011. Terapevticheskii arkhiv. 2013; 4: 4–10. [In Russ].; Ганюков В . И . Организация быстрого доступа больных инфарктом миокарда с подъемом сегмента ST в цен тры первичного ЧКВ. Комплексные проблемы сердечнососудистых заболеваний. 2013; 1:44–51. Ganyukov V. I. Short time delivery of STEMI patients to PCI centers. Complex Issues of cardiovascular diseases. 2013; 1: 44–51. [In Russ].; Dambrink J. H., Debrauwere J. P., van‘t Hof A. W., Ottervanger J. P., Gosselink A. T., Hoorntje J. C. et al. Nonculprit lesions detected during primary PCI: treat invasively or follow the guidelines? Eurointervention. 2010; 5:968–975.; Cardarelli F., Bellasi A., Ou F. S., Shaw L. J., Veledar E., Roe M. T. et al. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry). Am. J. Cardiol. 2009; 103: 766–771.; Addala S., Grines C. L., Dixon S. R., Stone G. W., Boura J. A., Ochoa A. B. et al. Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am. J. Cardiol. 2004; 93:629–632.; Halkin A., Singh M., Nikolsky E., Grines C. L., Tcheng J. E., Garcia E. et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J. Am. Coll. Cardiol. 2005; 45:1397–1405.; Eagle K. A., Lim M. J., Dabbous O. H. GRACE Investigators et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004; 291:2727–2733.; De Luca G., Suryapranata H., van‘t Hof A. W., de Boer M. J., Hoorntje J. C., Dambrink J. H. et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation. 2004; 109:2737–2743.; Windecker S., Kolh P., Alfonso F., Collet J. P., Cremer J., Falk V. et al. 2014 ESC/EACTS Guidelines onmyocardial revascularization. Eur. Heart J. 2014; 278:25-27. doi:10.1093/ eurheartj/ehu.; Wald D. S., Morris J. K., Wald N. J., Chase A. J., Edwards R. J., Hughes L. O. et al. Randomized trial of preventive angioplasty in myocardial infarction. N. Engl. J. Med. 2013; 369(12):1115–1123.; Erne P. Radovanovic D., Urban Ph., Stauffer J. Ch., Bertel O., Gutzwiller F. et al. Early drug therapy and in-hospital mortality following acute myocardial infarction. Heart Drug. 2003: 3:34–140.; Hochman J. S., Tamis J. E., Thompson T. D., Weaver W. D., White H. D., Van de Werf F. et al. Sex, Clinical Presentation, and Outcome in Patients with Acute Coronary Syndromes. N. Engl. J. Med. 1999; 341:226–232.; Haq I., Sharif M. A. In-hospital Mortality after Acute Myocardial infarction. Pakistan’s J. Med. Sci. 1993; 9: 249–251.; Tarasov R. S., Ganyukov V. I., Protopopov A. V., Barbarash O. L., Barbarash L. S. Six month results of randomized clinical trial: Multivessel stenting versus staged revascularization for ST-elevation myocardial infarction patients with second generation drug eluting stents. Clinical Medicine Research. 2014; 3(5):125–129. doi:10.11648/j.cmr. 20140305.12.

Διαθεσιμότητα: https://www.nii-kpssz.com/jour/article/view/113
https://doi.org/10.17802/2306-1278-2015-1-32-38

View record from BASE

9

Academic Journal